H79TI087774
Project Grant
Overview
Grant Description
New Jersey State Opioid Response (NJ SOR) - The goals of the New Jersey Department of Human Services' Division of Mental Health and Addiction Services' (DMHAS) New Jersey State Opioid Response (NJ-SOR) project are to:
1) Increase access to FDA-approved medications for opioid use disorder (MOUD);
2) Support the continuum of prevention, harm reduction, treatment, and recovery support services for opioid use disorder (OUD) and concurrent substance use disorders (SUDs);
3) Support the continuum of care for stimulant misuse and use disorders;
4) Reduce unmet treatment need; and
5) Reduce opioid-related overdose deaths.
DMHAS will continue to fund a variety of programs that were initiated under the previous SOR grants and implement new services to meet these goals.
The community of focus for the NJ SOR project are individuals with, or at risk for, opioid use and/or stimulant use disorder throughout the state.
DMHAS is targeting the entire state based on its needs assessment.
Virtually every indicator, from drug arrests to overdoses to treatment figures, shows that the opioid crisis has a firm grip on NJ.
NJ-SOR services include the expanded hours/same day service opioid treatment programs (OTPs) that provide same-day access to low barrier/on demand MOUD, the mobile MOUD program that facilitates low induction medication in communities with low access to MOUD and high rates of homelessness, and the low threshold buprenorphine induction initiative that implements "low threshold" buprenorphine induction and stabilization programs at statewide harm reduction centers.
Additionally, a program will continue to be funded to enhance overall recovery in stimulant use disorders utilizing contingency management.
Training opportunities will continue for OUD treatment professionals and recovery service workers and a new training initiative for school staff in substance misuse prevention will be implemented.
Prevention efforts will continue to include free naloxone kits that may be accessed through a portal developed for use by community groups, and through a network of pharmacies for distribution through the Naloxone 365 Pharmacy Program.
The opioid overdose recovery program and public education for older adults prevention programs will also be continued.
Recovery activities include the continuation of the community peer recovery and family support centers; and the support team for addiction recovery and the nurse care manager initiatives that provide case management and support services for individuals with an OUD.
SOR will provide additional support for the three recovery high schools in NJ and fund a transportation reimbursement program for individuals to access services.
New programming that will be funded by SOR include an integrated care program to promote the integration and co-location of physical and behavioral health care to improve wellness and physical health and a harm reduction initiative that will include education and supplies distribution.
SOR will also fund new public information campaigns to reduce stigma surrounding SUD diagnoses and treatment and strategic messaging on consequences of opioid and stimulant misuse and counterfeit fentanyl pills targeted to youth and new prevention programs targeted to schools.
Anticipated outcomes of the NJ-SOR include: reduction/abstinence from drugs and alcohol, increase in employment, reduced criminal justice involvement, increased social connectedness, and increased percentage of individuals completing treatment at the recommended level of care.
Additional outcomes include: reducing opioid overdoses, increasing retention in treatment, reducing the length of time to relapse and prolonging recovery, and increasing number of individuals receiving MOUD.
It is estimated that NJ-SOR will serve 201,347 individuals during the first year and 599,393 individuals over the three-year project.
1) Increase access to FDA-approved medications for opioid use disorder (MOUD);
2) Support the continuum of prevention, harm reduction, treatment, and recovery support services for opioid use disorder (OUD) and concurrent substance use disorders (SUDs);
3) Support the continuum of care for stimulant misuse and use disorders;
4) Reduce unmet treatment need; and
5) Reduce opioid-related overdose deaths.
DMHAS will continue to fund a variety of programs that were initiated under the previous SOR grants and implement new services to meet these goals.
The community of focus for the NJ SOR project are individuals with, or at risk for, opioid use and/or stimulant use disorder throughout the state.
DMHAS is targeting the entire state based on its needs assessment.
Virtually every indicator, from drug arrests to overdoses to treatment figures, shows that the opioid crisis has a firm grip on NJ.
NJ-SOR services include the expanded hours/same day service opioid treatment programs (OTPs) that provide same-day access to low barrier/on demand MOUD, the mobile MOUD program that facilitates low induction medication in communities with low access to MOUD and high rates of homelessness, and the low threshold buprenorphine induction initiative that implements "low threshold" buprenorphine induction and stabilization programs at statewide harm reduction centers.
Additionally, a program will continue to be funded to enhance overall recovery in stimulant use disorders utilizing contingency management.
Training opportunities will continue for OUD treatment professionals and recovery service workers and a new training initiative for school staff in substance misuse prevention will be implemented.
Prevention efforts will continue to include free naloxone kits that may be accessed through a portal developed for use by community groups, and through a network of pharmacies for distribution through the Naloxone 365 Pharmacy Program.
The opioid overdose recovery program and public education for older adults prevention programs will also be continued.
Recovery activities include the continuation of the community peer recovery and family support centers; and the support team for addiction recovery and the nurse care manager initiatives that provide case management and support services for individuals with an OUD.
SOR will provide additional support for the three recovery high schools in NJ and fund a transportation reimbursement program for individuals to access services.
New programming that will be funded by SOR include an integrated care program to promote the integration and co-location of physical and behavioral health care to improve wellness and physical health and a harm reduction initiative that will include education and supplies distribution.
SOR will also fund new public information campaigns to reduce stigma surrounding SUD diagnoses and treatment and strategic messaging on consequences of opioid and stimulant misuse and counterfeit fentanyl pills targeted to youth and new prevention programs targeted to schools.
Anticipated outcomes of the NJ-SOR include: reduction/abstinence from drugs and alcohol, increase in employment, reduced criminal justice involvement, increased social connectedness, and increased percentage of individuals completing treatment at the recommended level of care.
Additional outcomes include: reducing opioid overdoses, increasing retention in treatment, reducing the length of time to relapse and prolonging recovery, and increasing number of individuals receiving MOUD.
It is estimated that NJ-SOR will serve 201,347 individuals during the first year and 599,393 individuals over the three-year project.
Funding Goals
ADDRESSING THE OPIOID ABUSE CRISIS WITHIN SUCH STATES, USED FOR CARRYING OUT ACTIVITIES THAT SUPPLEMENT ACTIVITIES PERTAINING TO OPIOIDS UNDERTAKEN BY THE STATE AGENCY RESPONSIBLE FOR ADMINISTERING THE SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT UNDER SUBPART II OF PART B OF TITLE XIX OF THE PUBLIC HEALTH SERVICE ACT (42 U.S.C. 300X21 ET SEQ.), AND TRIBES AND TRIBAL ORGANIZATIONS TO ADDRESS THE OPIOID CRISIS WITHIN THEIR COMMUNITIES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New Jersey
United States
Geographic Scope
State-Wide
Related Opportunity
New Jersey Department Of Human Services was awarded
NJ SOR: Opioid Response & Recovery Initiative
Project Grant H79TI087774
worth $68,788,243
from the Division of Grants Management in September 2024 with work to be completed primarily in New Jersey United States.
The grant
has a duration of 3 years and
was awarded through assistance program 93.788 Opioid STR.
The Project Grant was awarded through grant opportunity State Opioid Response Grants.
Status
(Ongoing)
Last Modified 2/20/25
Period of Performance
9/30/24
Start Date
9/29/27
End Date
Funding Split
$68.8M
Federal Obligation
$0.0
Non-Federal Obligation
$68.8M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for H79TI087774
Transaction History
Modifications to H79TI087774
Additional Detail
Award ID FAIN
H79TI087774
SAI Number
H79TI087774-3536727438
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75SAMH SAMHSA DIVISION OF GRANTS MANAGEMENT
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
MLGMLZ76EMC3
Awardee CAGE
37SY2
Performance District
NJ-90
Senators
Robert Menendez
Cory Booker
Cory Booker
Modified: 2/20/25